PA
Perceptive Advisors Portfolio holdings
AUM
$2.67B
This Quarter Return
+41.54%
1 Year Return
+73.17%
3 Year Return
+837.18%
5 Year Return
+928.4%
10 Year Return
+11,818.46%
AUM
$6.16B
AUM Growth
+$6.16B
(+61%)
Cap. Flow
+$315M
Cap. Flow
% of AUM
5.11%
Top 10 Holdings %
Top 10 Hldgs %
45.74%
Holding
148
New
33
Increased
26
Reduced
17
Closed
23
Top Buys
| 1 |
FMTX
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
|
$58.1M |
| 2 |
Zentalis Pharmaceuticals
ZNTL
|
$45.8M |
| 3 |
ZGNX
Zogenix, Inc.
ZGNX
|
$39.3M |
| 4 |
Lyra Therapeutics
LYRA
|
$36.5M |
| 5 |
MacroGenics
MGNX
|
$36M |
Top Sells
| 1 |
Neurocrine Biosciences
NBIX
|
$112M |
| 2 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$62.6M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
$40.5M |
| 4 |
Theravance Biopharma
TBPH
|
$23.1M |
| 5 |
NVRO
NEVRO CORP.
NVRO
|
$22.9M |
Sector Composition
| 1 | Healthcare | 82.47% |
| 2 | Materials | 0.1% |
| 3 | Technology | 0.1% |
| 4 | Consumer Discretionary | 0.02% |
| 5 | Communication Services | 0.02% |
